Escherichia coli Nissle 1917 facilitates tumor detection by positron emission tomography and optical imaging

Clinical Cancer Research

Volumn 14, Issue 8, 2008, Pages 2295-2302

  Brader, Peter ^a   Stritzker, Jochen ^b,c   Riedl, Christopher C ^a   Zanzonico, Pat ^a   Cai, Shangde ^a   Burnazi, Eva M ^a   Ghani, E Rashid ^a   Hricak, Hedvig ^a   Szalay, Aladar A ^b,c,d   Fong, Yuman ^a   Blasberg, Ronald ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b San Diego Science Center ^*  (United States)

^c Institute for Biochemistry

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 ETHYL 2' FLUOROURACIL ARABINOSIDE F 18; FIALURIDINE F 18; FLUORODEOXYGLUCOSE F 18; LUCIFERASE; PYRIMIDINE NUCLEOSIDE DERIVATIVE; TRACER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BIOLUMINESCENCE; BREAST TUMOR; CANCER DIAGNOSIS; CONTROLLED STUDY; ESCHERICHIA COLI; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ANIMALS; ARABINOFURANOSYLURACIL; CELL LINE, TUMOR; ESCHERICHIA COLI; FLUORODEOXYGLUCOSE F18; HERPESVIRUS 1, HUMAN; MICE; NEOPLASMS, EXPERIMENTAL; POSITRON-EMISSION TOMOGRAPHY; PROBIOTICS; THYMIDINE KINASE; TISSUE DISTRIBUTION;

EID: 42249100493     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-4254     Document Type: Article

References (26)

1. Liu TC, Kirn D. Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directions. Cancer Res 2007;67:429-32.
2. Yu YA, Shabahang S, Timiryasova TM, et al. Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins. Nat Biotechnol 2004;22:313-20.
3. Kimura NT, Taniguchi S, Aoki K, Baba T. Selective localization and growth of Bifidobacterium bifidum in mouse tumors following intravenous administration. Cancer Res 1980;40:2061-8.
4. Riedel CU, Monk IR, Casey PG, et al. An improved luciferase tagging system for Listeria monocytogenes allows real-time monitoring in vivo and in vitro. Appl Environ Microbiol 2007;73:3091-4.
5. Bettegowda C, Foss CA, Cheong I, et al. Imaging bacterial infections with radiolabeled 1-(2′-deoxy-2′-fluoro-β-D- arabinofuranosyl)-5-iodouracil. Proc Natl Acad Sci U S A 2005;102:1145-50.
6. Stritzker J, Weibel S, Hill PJ, Oelschlaeger TA, Goebel W, Szalay AA. Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in livemice. Int J Med Microbiol 2007;297:51-62.
7. Toso JF, Gill VJ, Hwu P, et al. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. JClin Oncol 2002;20:142-52.
8. Yu W, Fang H. Clinical trials with oncolytic adenovirus in China. Curr Cancer Drug Targets 2007;7:141-8.
9. Zhao M, Yang M, Li XM, et al. Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc Natl Acad Sci U S A 2005;102:755-60.
10. Rennen HJ, Boerman OC, Oyen WJ, Corstens FH. Imaging infection/ inflammation in the new millennium. Eur J Nucl Med 2001;28:241-52.
11. 18F]FEAU) as markers for suicide gene expression. Eur J Nucl Med Mol Imaging 2007;34:822-9.
12. Serganova I, Doubrovin M, Vider J, et al. Molecular imaging of temporal dynamics and spatial heterogeneity of hypoxia-inducible factor-1 signal transduction activity in tumors in living mice. Cancer Res 2004;64:6101- 8.
13. Tjuvajev JG, Avril N, Oku T, et al. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res 1998;58:4333-41.
14. Tjuvajev JG, Doubrovin M, Akhurst T, et al. Comparison of radiolabeled nucleoside probes (FIAU, FHBG, FHPG) for PET imaging of HSV1-tk gene expression. J Nucl Med 2002;43:1072-83.
15. Jacobs A, Voges J, Reszka R, et al. Positronemission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet 2001;358:727-9.
16. Soghomonyan SA, Doubrovin M, Pike J, et al. Positron emission tomography (PET) imaging of tumor-localized Salmonella expressing HSV1-TK. Cancer Gene Ther 2005;12:101-8.
17. Francis KP, JohD, Bellinger-KawaharaC,Hawkinson MJ, Purchio TF, Contag PR. Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct. Infect Immun 2000;68:3594-600.
18. Sartor RB. Probiotic therapy of intestinal inflammation and infections. Curr Opin Gastroenterol 2005;21:44-50.
19. Altenhoefer A, Oswald S, Sonnenborn U, et al. The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens. FEMS Immunol Med Microbiol 2004;40:223-9.
20. Sun J, Gunzer F, Westendorf AM, et al. Genomic peculiarity of coding sequences and metabolic potential of probiotic Escherichia coli strain Nissle 1917 inferred from raw genome data. J Biotechnol 2005;117:147-61.
21. Blum G, Marre R, Hacker J. Properties of Escherichia coli strains of serotype O6. Infection 1995;23:234-6.
22. 18F-FEAU as a radiotracer for herpes simplex virus thymidine kinase gene expression: in vitro comparison with other PET tracers. Nucl Med Commun 2006;27:25-30.
23. Bennett JJ, Tjuvajev J, Johnson P, et al. Positron emission tomography imaging for herpes virus infection: implications for oncolytic viral treatments of cancer. Nat Med 2001;7:859-63.
24. 18F]FHBG. Nat Protoc 2006;1:3069-75.
25. 18F-FHBG: a PET reporter probe for imaging herpes simplex virus type 1thymidine kinase (HSV1-tk) or mutant HSV1-39tk's expression. J Nucl Med 2006;47:706-15.
26. Peñuelas I, Mazzolini G, Boán JF, et al. Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients. Gastroenterology 2005;128:1787-95.